Advanced Serial Plasma Exchange Arrives in Atlanta as Environmental Exposure Concerns Grow Across Metro Region

ATLANTA, GA — (Month XX, 2026) — MDLifespan (www.mdlifespan.com), leaders in removing toxins and reversing chronic inflammation, today announced the launch of its Advanced Serial Therapeutic Plasma Exchange (TPE) protocols inside Cenegenics Atlanta, expanding access to physician-directed toxin reduction services in Georgia.

The integration introduces MDLifespan’s multi-session plasma exchange protocols designed to help remove circulating environmental toxins and inflammatory proteins from the bloodstream, offering patients in the Atlanta region access to one of the most advanced physician-led toxin reduction programs currently available in outpatient clinical settings.

The launch comes as scientific research continues to examine the growing role environmental toxin exposure may play in chronic disease development.

A growing body of research suggests that persistent environmental chemicals circulating in the bloodstream may contribute to systemic inflammation, oxidative stress, immune dysregulation, and biological disruptions associated with conditions such as Parkinson’s disease, cardiovascular disease, metabolic dysfunction, and certain cancers.

As awareness increases around the long-term health implications of environmental exposures, more patients are seeking physician-directed strategies to evaluate toxin burden and reduce inflammatory stress at the circulatory level.

Why Atlanta?

Metro Atlanta represents one of the largest and fastest-growing metropolitan regions in the United States, with more than six million residents living within a complex network of transportation corridors, industrial activity, and dense urban development.

While the city continues to experience rapid economic growth, public health research and environmental monitoring reports have also identified several exposure risks relevant to long-term health.

These include:

• Elevated ozone pollution levels

• Short-term particle pollution (PM2.5) associated with cardiovascular stress

• Industrial chemical releases into waterways

• Persistent PFAS contamination in parts of North Georgia

• Localized soil contamination including elevated lead levels in certain communities

In 2025, Fulton and Henry counties received failing grades for ozone pollution, while several surrounding counties received lower grades due to particle pollution and smog levels.

Atlanta’s role as a major transportation hub anchored by the world’s busiest airport also contributes to environmental exposure concerns, particularly in relation to transportation-related air pollution and particulate emissions.

Short-term particle pollution (PM2.5) has been associated in research literature with respiratory stress, cardiovascular strain, and inflammatory responses within the body.

Emerging Research on Environmental Toxins and Disease Risk

Environmental health researchers increasingly emphasize that many toxins do not simply remain in the environment — they can accumulate in the human body over time.

Persistent chemicals including PFAS (“forever chemicals”), heavy metals, industrial solvents, microplastics, and other environmental pollutants may circulate within the bloodstream and interact with biological systems.

Scientific studies have increasingly explored how chronic toxin exposure may contribute to:

• systemic inflammation

• oxidative stress

• endothelial dysfunction

• immune dysregulation

• neurological stress pathways

These biological processes are being studied as contributing factors in the development or progression of neurodegenerative disease, cardiovascular disease, metabolic disorders, autoimmune conditions, and certain cancers.

Because many toxins remain in the body for years or even decades, researchers continue to explore strategies for measuring and reducing circulating toxin burden.

Addressing Circulating Toxins at the Bloodstream Level

The integration of MDLifespan’s Advanced Serial Plasma Exchange protocols inside Cenegenics Atlanta provides patients access to a structured, physician-supervised approach designed to help reduce circulating toxins and inflammatory proteins.

Therapeutic Plasma Exchange is an established medical technology historically used in hospital settings to treat certain autoimmune and neurological conditions.

MDLifespan adapts this technology into standardized outpatient protocols designed to address modern environmental exposure concerns through physician-led care models.

“Environmental exposure is becoming an increasingly important part of the health conversation across the country,” said Dr. Paul Savage, Founder and Chief Medical Officer of MDLifespan.

“Research is beginning to demonstrate how long-term toxin accumulation may contribute to biological stress and systemic inflammation that can increase the risk for chronic diseases including neurodegenerative disorders, cardiovascular disease, and cancer. Our Advanced Serial Plasma Exchange protocols are structured physician-supervised programs designed to support measurable reductions in circulating toxin burden while integrating advanced biomarker analysis.”

What Patients in Atlanta Now Have Access To

Through the Cenegenics Atlanta integration, patients can now access:

• Multi-session physician-led Advanced Serial Therapeutic Plasma Exchange protocols

• Comprehensive diagnostics focused on environmental toxin exposure

• Biomarker testing to evaluate inflammation and toxin burden

• Structured clinical pathways designed to reduce systemic inflammatory load

• Ongoing monitoring and physician oversight

Each MDLifespan protocol begins with advanced diagnostic testing designed to evaluate toxin burden and inflammatory biomarkers, followed by a series of plasma exchange sessions designed to support toxin reduction at the circulatory level.

Progress is monitored through objective laboratory testing and physician review.

Integrating Precision Diagnostics with Plasma Exchange

The collaboration reflects a broader evolution in personalized medicine, combining advanced diagnostics with physician-guided therapeutic interventions.

MDLifespan’s clinical model integrates:

• precision biomarker analysis

• environmental toxin testing

• serial plasma exchange protocols

• physician-directed care pathways

Rather than positioning plasma exchange as a single treatment event, MDLifespan delivers structured protocols designed to support measurable biological change over time.

Supporting National Expansion of Physician-Led Toxin Reduction

The Atlanta integration supports MDLifespan’s national expansion strategy, which focuses on partnering with established physician-led clinics across the United States.

The company’s expansion strategy centers on:

• integrating into existing performance and longevity medicine centers

• delivering standardized Advanced Serial TPE protocols

• expanding geographic access to toxin reduction services

• supporting physician-directed care models focused on inflammation and toxin burden

As environmental toxin exposure becomes a growing topic in public health research and preventative medicine, MDLifespan positions Advanced Serial Therapeutic Plasma Exchange as a physician-directed strategy designed to address circulating toxin burden at the bloodstream level.

About MDLifespan

MDLifespan is a physician-led medical technology startup and certified Public Benefit Corporation delivering advanced detoxification and regenerative medicine solutions through Advanced Therapeutic Plasma Exchange. Founded by Dr. Paul Savage, MDLifespan focuses on removing environmental toxins and reversing chronic inflammation using clinically validated, personalized, and patented protocols.

About Cenegenics

Founded in 1997, Cenegenics is the global leader in performance health medicine and longevity. The company delivers personalized, physician-led programs grounded in comprehensive biomarker analysis, advanced diagnostics, evidence-based therapies, and continuous optimization.